The product is recommended only when all other methods have been shown to be inadequate, especially with terminal patients or those with chronic problems that cannot be managed otherwise.
Actually, very few physicians prescribe it. We talk about it, but in our offices, we can't say that it is a prescription. A prescription is based on proven data, so that when we prescribe a product, we become responsible for the interactions, the side effects, and so on.
So, for physicians, this is not an acceptable prescription at the moment. That is why we want one single distribution method for cannabis.